Cargando…
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers
In preclinical studies serotonin stimulates and dopamine inhibits tumour growth and angiogenesis. Information regarding serotonin and dopamine receptor (5-HTR and DRD) expression in human cancers is limited. Therefore, we screened a large tumour set for receptor mRNA overexpression using functional...
Autores principales: | Peters, Marloes A. M., Meijer, Coby, Fehrmann, Rudolf S. N., Walenkamp, Annemiek M. E., Kema, Ido P., de Vries, Elisabeth G. E., Hollema, Harry, Oosting, Sjoukje F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297821/ https://www.ncbi.nlm.nih.gov/pubmed/31478179 http://dx.doi.org/10.1007/s12253-019-00734-w |
Ejemplares similares
-
Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape
por: Oosting, Sjoukje F, et al.
Publicado: (2017) -
Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020) -
Total (18)F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
por: Fiebrich, Helle-Brit, et al.
Publicado: (2011) -
Automated mass spectrometric analysis of urinary and plasma serotonin
por: de Jong, Wilhelmina H. A., et al.
Publicado: (2010) -
Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage
por: Altena, Renske, et al.
Publicado: (2015)